nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys
|
Jagessar, S. Anwar |
|
2012 |
7 |
3 |
p. 557-570 |
artikel |
2 |
Antioxidant Sestrin-2 Redistribution to Neuronal Soma in Human Immunodeficiency Virus-Associated Neurocognitive Disorders
|
Soontornniyomkij, Virawudh |
|
2012 |
7 |
3 |
p. 579-590 |
artikel |
3 |
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up-regulation of Serum IgE Levels in Immunized Mice
|
Newton, Catherine A. |
|
2012 |
7 |
3 |
p. 591-598 |
artikel |
4 |
Chronic Lithium Feeding Reduces Upregulated Brain Arachidonic Acid Metabolism in HIV-1 Transgenic Rat
|
Ramadan, Epolia |
|
2012 |
7 |
3 |
p. 701-713 |
artikel |
5 |
Comparison of the D2 Receptor Regulation and Neurotoxicant Susceptibility of Nigrostriatal Dopamine Neurons in Wild-Type and CB1/CB2 Receptor Knockout Mice
|
Simkins, Tyrell J. |
|
2012 |
7 |
3 |
p. 533-538 |
artikel |
6 |
D1/NMDA Receptors and Concurrent Methamphetamine+HIV-1 Tat Neurotoxicity
|
Aksenov, Michael Y. |
|
2012 |
7 |
3 |
p. 599-608 |
artikel |
7 |
Do Opioids Activate Latent HIV-1 by Down-Regulating Anti-HIV microRNAs?
|
Purohit, Vishnudutt |
|
2012 |
7 |
3 |
p. 519-523 |
artikel |
8 |
Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice
|
Luo, Zhongqiu |
|
2012 |
7 |
3 |
p. 640-655 |
artikel |
9 |
Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice
|
Luo, Zhongqiu |
|
|
7 |
3 |
p. 640-655 |
artikel |
10 |
HIV-1 Tat Protein Decreases Dopamine Transporter Cell Surface Expression and Vesicular Monoamine Transporter-2 Function in Rat Striatal Synaptosomes
|
Midde, Narasimha M. |
|
2012 |
7 |
3 |
p. 629-639 |
artikel |
11 |
Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan
|
Chen, Shiou-Lan |
|
2012 |
7 |
3 |
p. 656-664 |
artikel |
12 |
Inflammation in Patients with Schizophrenia: The Therapeutic Benefits of Risperidone Plus Add-On Dextromethorphan
|
Chen, Shiou-Lan |
|
|
7 |
3 |
p. 656-664 |
artikel |
13 |
Maternal Immune Activation Increases Neonatal Mouse Cortex Thickness and Cell Density
|
Smith, Stephen E. P. |
|
2012 |
7 |
3 |
p. 529-532 |
artikel |
14 |
Mitochondrial Glutaminase Release Contributes to Glutamate-Mediated Neurotoxicity during Human Immunodeficiency Virus-1 Infection
|
Tian, Changhai |
|
2012 |
7 |
3 |
p. 619-628 |
artikel |
15 |
Nanoparticle Based Galectin-1 Gene Silencing, Implications in Methamphetamine Regulation of HIV-1 Infection in Monocyte Derived Macrophages
|
Reynolds, Jessica L. |
|
2012 |
7 |
3 |
p. 673-685 |
artikel |
16 |
Near-field Quantification of Complement Receptor 1 (CR1/CD35) Protein Clustering in Human Erythrocytes
|
Lapin, Zachary J. |
|
2012 |
7 |
3 |
p. 539-543 |
artikel |
17 |
Neuroprotective Effect of Curcuminoids Against Inflammation-Mediated Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
|
Ojha, Rudra P. |
|
2012 |
7 |
3 |
p. 609-618 |
artikel |
18 |
Prefrontal Dopaminergic and Enkephalinergic Synaptic Accommodation in HIV-associated Neurocognitive Disorders and Encephalitis
|
Gelman, Benjamin B. |
|
2012 |
7 |
3 |
p. 686-700 |
artikel |
19 |
Repulsive Guidance Molecule-a and Demyelination: Implications for Multiple Sclerosis
|
Kubo, Takekazu |
|
2011 |
7 |
3 |
p. 524-528 |
artikel |
20 |
Synapse Loss Induced by Interleukin-1β Requires Pre- and Post-synaptic Mechanisms
|
Mishra, Anjuli |
|
2012 |
7 |
3 |
p. 571-578 |
artikel |
21 |
Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys
|
Mondal, Susanta |
|
2012 |
7 |
3 |
p. 544-556 |
artikel |
22 |
The Role of Gap Junction Channels During Physiologic and Pathologic Conditions of the Human Central Nervous System
|
Eugenin, Eliseo A. |
|
|
7 |
3 |
p. 499-518 |
artikel |
23 |
The Role of Gap Junction Channels During Physiologic and Pathologic Conditions of the Human Central Nervous System
|
Eugenin, Eliseo A. |
|
2012 |
7 |
3 |
p. 499-518 |
artikel |
24 |
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
|
Laroni, A. |
|
2012 |
7 |
3 |
p. 665-672 |
artikel |